BioSpace News Archive

Pharm Country

Advaxis to Receive $4.5 Million Through the New Jersey Economic Development Authority NOL Program

The company anticipates it will be able to transfer this credit and receive $4.5 million in cash by the end of 2017.

November 1, 2017

·

3 min read

Biotech Bay

Quark Pharmaceuticals Phase II Data on the Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery to Be Presented at the American Society of Nephrology Meeting

Quark announced that Phase 2 data on its lead program QPI-1002 will be presented as an oral abstract at the American Society of Nephrology (ASN) / Kidney Week being held in New Orleans, LA from October 31 through November 5, 2017.

November 1, 2017

·

4 min read

Business

Purdue Pharma Joins the Prescription Drug Safety Network

The course includes interactive sessions and self-guided activities to empower students with knowledge, skills, and strategies to help prevent prescription drug misuse and abuse.

November 1, 2017

·

4 min read

Deals

Ethismos Research Closes Deal to Acquire the Intellectual Property Assets of Euthymics Bioscience

This is comprised of twelve families of patents and patent applications including those underlying amitifadine, a serotonin-preferring triple reuptake inhibitor previously under phase 2 development by Euthymics.

November 1, 2017

·

4 min read

Business

ImmusanT Blood Test Differentiates Celiac From Non-Celiac Patients Through Cytokine Levels

ImmusanT today announced data from its collaboration with Norwegian researchers demonstrating an ability to differentiate celiac disease and non-celiac gluten-sensitive patients based on cytokine levels.

November 1, 2017

·

5 min read

Genetown

Charles River Laboratories Presents Newly Expanded Capabilities at Neuroscience 2017

The meeting, which brings together over 30,000 researchers from more than 80 countries, is taking place from November 11-15 in Washington, DC.

November 1, 2017

·

5 min read

Business

ImmunoMet Appoints Benjamin R. Cowen, PhD, MBA, as CEO

ImmunoMet Therapeutics today announced the appointment of Benjamin R. Cowen, PhD, MBA, as CEO, effective November 1, 2017.

November 1, 2017

·

3 min read

Drug Development

Theravance Biopharma and Mylan Report Additional Positive Phase III Data for Revefenacin (TD-4208) in Multiple Presentations at 2017 CHEST Annual Meeting

James F. Donohue, MD, Professor of Medicine, Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill, presented new data from the completed three-month Phase III studies.

November 1, 2017

·

15 min read

Business

Tenaya Therapeutics Appoints Tim Hoey, Ph.D. as CSO

Dr. Hoey is a biopharmaceutical executive with over two decades of experience in the industry.

November 1, 2017

·

2 min read

Pharm Country

Genisphere Raises $7M to Advance 3DNA Drug Delivery System

Genisphere completed the raise to support accelerating interest in advancing its 3DNA scaffold into the clinic and enabling follow-on studies and programs currently underway with biotech and pharma partners.

November 1, 2017

·

2 min read